Abstract
Angiogenesis, defined as the growth of new blood vessels from existing ones, plays a key role in development, growth, and tissue repair. Its necessary role in tumor growth and metastasis has led to the creation of a new category of anti-angiogenic cancer therapies. Preclinical development and evaluation of potential drug candidates require models that mimic real microvascular networks. Here, we describe the rat mesentery culture model as a simple ex vivo assay that offers time-lapse imaging of intact microvascular network remodeling and demonstrate its application for anti-angiogenic drug testing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kaunas R, Kang H, Bayless KJ (2011) Synergistic regulation of angiogenic sprouting by biochemical factors and wall shear stress. Cell Mol Bioeng 4(4):547–559. doi:10.1007/s12195-011-0208-5
Nicosia RF, Ottinetti A (1990) Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63(1):115–122
Chan JM, Zervantonakis IK, Rimchala T, Polacheck WJ, Whisler J, Kamm RD (2012) Engineering of in vitro 3D capillary beds by self-directed angiogenic sprouting. PLoS One 7(12):e50582. doi:10.1371/journal.pone.0050582
Song JW, Munn LL (2011) Fluid forces control endothelial sprouting. Proc Natl Acad Sci U S A 108(37):15342–15347. doi:10.1073/pnas.1105316108
Peirce SM, Mac Gabhann F, Bautch VL (2012) Integration of experimental and computational approaches to sprouting angiogenesis. Curr Opin Hematol 19(3):184–191. doi:10.1097/MOH.0b013e3283523ea6
Norrby K, Franzen L (1980) A tissue model for the study of cell proliferation in vitro. In Vitro 16(1):31–37
Stapor PC, Azimi MS, Ahsan T, Murfee WL (2013) An angiogenesis model for investigating multicellular interactions across intact microvascular networks. Am J Physiol Heart Circ Physiol 304(2):H235–245. doi:10.1152/ajpheart.00552.2012
Azimi MS, Myers L, Lacey M, Stewart SA, Shi Q, Katakam PV, Mondal D, Murfee WL (2015) An ex vivo model for anti-angiogenic drug testing on intact microvascular networks. PLoS One 10(3):e0119227. doi:10.1371/journal.pone.0119227
Norrby K (2006) In vivo models of angiogenesis. J Cell Mol Med 10(3):588–612
Mathur A, Abd Elmageed ZY, Liu X, Kostochka ML, Zhang H, Abdel-Mageed AB, Mondal D (2014) Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells. PLoS One 9(8):e103109. doi:10.1371/journal.pone.0103109
Mondal D, Pradhan L, Ali M, Agrawal KC (2004) HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: exacerbation by inflammatory cytokines and amelioration by antioxidants. Cardiovasc Toxicol 4(3):287–302
Mondal D, Liu K, Hamblin M, Lasky JA, Agrawal KC (2013) Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones. Ochsner J 13(1):76–90
Bhandarkar SS, Arbiser JL (2007) Curcumin as an inhibitor of angiogenesis. Adv Exp Med Biol 595:185–195. doi:10.1007/978-0-387-46401-5_7
Lennernas B, Albertsson P, Damber JE, Norrby K (2004) Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative study. APMIS 112(3):201–209. doi:10.1111/j.1600-0463.2004.apm1120306.x
Albertsson P, Lennernas B, Norrby K (2012) Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis. APMIS 120(2):147–156. doi:10.1111/j.1600-0463.2011.02830.x
Phamduy TB, Sweat RS, Azimi MS, Burow ME, Murfee WL, Chrisey DB (2015) Printing cancer cells into intact microvascular networks: a model for investigating cancer cell dynamics during angiogenesis. Integr Biol (Camb) 7(9):1068–1078. doi:10.1039/c5ib00151j
Sweat RS, Sloas DC, Murfee WL (2014) VEGF-C induces lymphangiogenesis and angiogenesis in the rat mesentery culture model. Microcirculation 21(6):532–540. doi:10.1111/micc.12132
Acknowledgment
This work was supported by National Institutes of Health Grant 5-P20GM103629-04 to WLM and the Tulane Center for Aging and the Tulane Hypertension and Renal Center of Excellence.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Azimi, M.S., Lacey, M., Mondal, D., Murfee, W.L. (2016). An Ex Vivo Tissue Culture Model for Anti-angiogenic Drug Testing. In: Ribatti, D. (eds) Tumor Angiogenesis Assays. Methods in Molecular Biology, vol 1464. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3999-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3999-2_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3997-8
Online ISBN: 978-1-4939-3999-2
eBook Packages: Springer Protocols